Invitrogen Looks To Limit Damages From Patent Suit

Law360, New York (October 3, 2007, 12:00 AM EDT) -- Life sciences company Invitrogen Corp. on Tuesday filed a motion that seeks to limit the potential damages in a lawsuit that accuses it of infringing a patent related to the introduction of DNA into the nucleus of living cells.

In a motion for partial summary judgment, Invitrogen alleged that Genetic Applications LLC should be barred from recovering any damages incurred between July 1999 and August 2004.

The Carlsbad, Calif.-based company pointed out that the patent in question “shall be enforceable only for and during such period...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.